1 Sept 2026Open access
Expression Of the Idh1 R132h Protein in Hepatopancreatobiliary Malignancies in A Single Center Population: Immunohistochemical Study.Publisher sitePubMed, Cholangiocarcinoma and Gallbladder Cancer Studies
Active, last published 2026
In hepatocellular carcinoma treatment and prognosis
Sara Mohamed Abd
Elhamed
Scholar“Research focused on Hepatocellular Carcinoma Treatment and Prognosis and adjacent fields.”
Menoufia University
Egypt
Claim Your ProfileEgypt2
H-index
24
Citations
Sara has not officially claimed their profile. If you are Sara, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ara Mohamed Abd Elhamed is a researcher working on Hepatocellular Carcinoma Treatment and Prognosis. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sara's work has been cited 24 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hepatocellular Carcinoma Treatment and Prognosis×3Cholangiocarcinoma and Gallbladder Cancer Studies×2Parasitic infections in humans and animals×2
04 · Where I am
Affiliations
Affiliation on published researchMenoufia University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works26 Mar 2024Open access2cites
STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinomaPublisher siteWorld Journal of Surgical Oncology, Ion Channels and Receptors
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sara?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you